Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | USP2 | O75604 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9280243 | 0.72 | TSHR (0.36) | ALDH1A1 | |
| SCHEMBL9715391 | 0.71 | — | — | |
| SCHEMBL3002127 | 0.71 | — | — | |
| SCHEMBL28351627 | 0.71 | TSHR (0.53) | LMNAALDH1A1CYP3A4SMN1; SMN2HPGD | |
| SCHEMBL13350494 | 0.70 | — | — | |
| SCHEMBL28355958 | 0.70 | TSHR (0.56) | LMNAALDH1A1CYP3A4SMN1; SMN2HPGD | |
| SCHEMBL28935992 | 0.70 | ALDH1A1 (0.38) | LMNAALDH1A1USP2SMN1; SMN2 | |
| SCHEMBL829692 | 0.70 | PRMT3 (0.44) | ALDH1A1 | |
| SCHEMBL8781867 | 0.68 | ALDH1A1 (0.41) | ALDH1A1 | |
| SCHEMBL11838143 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3443951-A1 | SUPERFATTING AGENT AND PERSONAL CARE COMPOSITION | Sabo S.p.A. (IT) | 2019-02-20 | — | — | EP | disclosed |
| EP-1952880-B1 | THERMAL EXPANSION MICROSPHERES AND PROCESS FOR PRODUCING THEM | BRIDGESTONE CORP (JP) | 2016-08-03 | — | — | EP | disclosed |
| US-8278350-B2 | Agent for skin external use containing salt of ascorbic acid derivative, method for stabilizing the agent for skin external use, and stabilizer | SHOWA DENKO K.K. (JP) | 2012-10-02 | — | — | US | disclosed |
| US-8242169-B2 | Emulsion composition | SHOWA DENKO K.K. (JP) | 2012-08-14 | — | — | US | disclosed |
| US-20120080131-A1 | HEAT-EXPANDABLE MICROSPHERES AND HOLLOW FINE PARTICLES AND METHOD FOR PRODUCING THE SAME AS WELL AS TIRE/RIM ASSEMBLY | MATSUMOTO YUSHI-SEIYAKU CO., LTD. (JP) | 2012-04-05 | — | — | US | disclosed |
| US-20100180995-A1 | HEAT-EXPANDABLE MICROSPHERES AND HOLLOW FINE PARTICLES AND METHOD FOR PRODUCING THE SAME AS WELL AS TIRE/RIM ASSEMBLY | BRIDGESTONE CORPORATION (JP) | 2010-07-22 | — | — | US | disclosed |
| US-20090252773-A1 | EMULSION COMPOSITION | SHOWA DENKO K.K. (JP) | 2009-10-08 | — | — | US | disclosed |
| EP-1660025-B1 | COSMETIC COMPOSITION CONTAINING A POLYOXYETHYL COMBINATION AND A LIPOPEPTIDE | SHOWA DENKO KK (JP) | 2009-07-15 | — | — | EP | disclosed |
| EP-2037869-A1 | EMULSION COMPOSITION | Showa Denko K.K. (JP) | 2009-03-25 | — | — | EP | disclosed |
| US-20080311234-A1 | Oil-in-Water Emulsified Composition, and External Preparation for Skin and Cosmetics Using the Composition | SHOWA DENKO K.K. (JP) | 2008-12-18 | — | — | US | disclosed |
| EP-1742606-A1 | OIL-IN-WATER EMULSIFIED COMPOSITION, AND EXTERNAL PREPARATION FOR SKIN AND COSMETICS USING THE COMPOSITION | Showa Denko K.K. (JP) | 2007-01-17 | — | — | EP | disclosed |
| US-20060222616-A1 | Cosmetic composition comprising a and a lipopeptide | KANEKA CORPORATION (JP) | 2006-10-05 | — | — | US | disclosed |
| EP-1689494-A1 | AGENT FOR SKIN EXTERNAL USE CONTAINING SALT OF ASCORBIC ACID DERIVATIVE, METHOD FOR STABILIZING THE AGENT FOR SKIN EXTERNAL USE, AND STABILIZER | Showa Denko K.K. (JP) | 2006-08-16 | — | — | EP | disclosed |
| EP-1660025-A1 | COSMETIC COMPOSITION CONTAINING A POLYOXYETHYL COMBINATION AND A LIPOPEPTIDE | Showa Denko K.K. (JP) | 2006-05-31 | — | — | EP | disclosed |
| WO-2005095462-A1 | MOISTURE RETENTION POLYMER COMPOUND | SHOWA DENKO K.K. (JP) | 2005-10-13 | — | — | WO | disclosed |
| WO-2005094777-A1 | EXTERNAL PREPARATION FOR SKIN | SHOWA DENKO K.K. (JP) | 2005-10-13 | — | — | WO | disclosed |
| US-20050220744-A1 | Polysaccharide/functional compound complex | SHOWA DENKO K.K. | 2005-10-06 | — | — | US | disclosed |
| WO-2005089708-A1 | OIL-IN-WATER EMULSIFIED COMPOSITION, AND EXTERNAL PREPARATION FOR SKIN AND COSMETICS USING THE COMPOSITION | SHOWA DENKO K.K. (JP) | 2005-09-29 | — | — | WO | disclosed |
| WO-2005034903-A1 | AGENT FOR SKIN EXTERNAL USE CONTAINING SALT OF ASCORBIC ACID DERIVATIVE, METHOD FOR STABILIZING THE AGENT FOR SKIN EXTERNAL USE, AND STABILIZER | SHOWA DENKO K.K. (JP) | 2005-04-21 | — | — | WO | disclosed |
| WO-2005020950-A1 | COSMETIC COMPOSITION COMPRISING A AND A LIPOPEPTIDE | SHOWA DENKO K.K. (JP) | 2005-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090252773-A1 | EMULSION COMPOSITION | ALOX5, ALOX15, ALOX15B | LMNA 1029/4885ALDH1A1 1056/4885USP2 3025/4885 |
| US-20060222616-A1 | Cosmetic composition comprising a and a lipopeptide | CUTA, SMURF1, FABP4 | LMNA 2265/4885ALDH1A1 3527/4885USP2 2502/4885 |
| US-20080311234-A1 | Oil-in-Water Emulsified Composition, and External Preparation for Skin and Cosmetics Using the Composition | CUTA, FPR1, FPR2 | LMNA 513/4885ALDH1A1 4783/4885USP2 3425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.